Recombinant TIGIT (Etigilimab Biosimilar) antibody

Catalog No. ABIN6964437

The Humanized Monoclonal anti-TIGIT (Etigilimab Biosimilar) antibody has been validated for ELISA and FACS. It is suitable to detect TIGIT (Etigilimab Biosimilar) in samples from Human.

Quick Overview for Recombinant TIGIT (Etigilimab Biosimilar) antibody (ABIN6964437)

Target: TIGIT (Etigilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This TIGIT (Etigilimab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-TIGIT (Etigilimab Biosimilar) Antibody

Purpose: Anti-TIGIT (etigilimab biosimilar) mAb

Characteristics: OMP-313M32

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for TIGIT (Etigilimab Biosimilar)

Target: TIGIT (Etigilimab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: TIGIT,VSIG9,VSTM3

UniProt: Q495A1